Kidney transplantation from living unrelated donors. 1992

R Sesso, and M J Klag, and M S Ancao, and P K Whelton, and A Seidler, and D Sigulem, and O L Ramos
Escola Paulista de Medicina, Division of Nephrology, Sao Paulo, Brazil.

OBJECTIVE To compare patient and graft survival of recipients of kidneys from living, unrelated donors (LUDs); cadaveric donors; and living, related donors (LRDs) matched for zero (mismatched), one, or two (identical) haplotypes. METHODS Cohort study. METHODS Sixty-three renal transplantation centers affiliated with the Brazilian Transplantation Registry (accounting for more than 95% of the transplantation activity in Brazil). METHODS Patients having renal transplantation between January 1987 and March 1991. Of 2892 patients, 165 (6%) received transplants from LUDs; 964 (33%), from cadaveric donors; 183 (6%), from zero haplotype, HLA-matched LRDs; 1259 (44%), from one haplotype-matched LRDs; and 321 (11%), from two haplotype-matched LRDs. METHODS Patient and graft survival. Patients were followed for an average of 15.8 months. RESULTS After adjustment for age, race, diagnosis of primary disease, history of previous transplantation, cyclosporine use, and number of transplants from LUDs per center, patient survival did not differ statistically for recipients of kidneys from LUDs and recipients of cadaveric kidneys (risk ratio [RR], 1.16; 95% Cl, 0.68 to 1.98). Little difference was seen between the adjusted death rate for recipients of zero haplotype-matched LRDs and recipients of cadaveric kidneys (RR, 1.13; Cl, 0.69 to 1.87). Similarly, in a multivariate analysis, recipients of kidneys taken from LUDs and zero haplotype-matched LRDs had a risk for graft failure that did not differ statistically from that of cadaveric kidney recipients (RR, 0.74; Cl, 0.45 to 1.22 and RR, 0.82; Cl, 0.53 to 1.25, respectively). CONCLUSIONS Graft survival for recipients of kidneys from LUDs is similar to that from zero haplotype-matched LRDs and is at least as good as that achieved with cadaveric transplants.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D001938 Brazil A country located on the eastern coast of South America, located between Colombia and Peru, that borders the Atlantic Ocean. It is bordered on the north by Venezuela, Guyana, Suriname, and French Guiana, on the south by Uruguay, and on the west by Argentina. The capital is Brasilia.
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue

Related Publications

R Sesso, and M J Klag, and M S Ancao, and P K Whelton, and A Seidler, and D Sigulem, and O L Ramos
January 1996, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
R Sesso, and M J Klag, and M S Ancao, and P K Whelton, and A Seidler, and D Sigulem, and O L Ramos
January 2000, Annual review of medicine,
R Sesso, and M J Klag, and M S Ancao, and P K Whelton, and A Seidler, and D Sigulem, and O L Ramos
September 1986, The New England journal of medicine,
R Sesso, and M J Klag, and M S Ancao, and P K Whelton, and A Seidler, and D Sigulem, and O L Ramos
January 1998, Clinical transplants,
R Sesso, and M J Klag, and M S Ancao, and P K Whelton, and A Seidler, and D Sigulem, and O L Ramos
October 1995, Transplantation proceedings,
R Sesso, and M J Klag, and M S Ancao, and P K Whelton, and A Seidler, and D Sigulem, and O L Ramos
April 2009, Current opinion in organ transplantation,
R Sesso, and M J Klag, and M S Ancao, and P K Whelton, and A Seidler, and D Sigulem, and O L Ramos
August 2001, Transplantation proceedings,
R Sesso, and M J Klag, and M S Ancao, and P K Whelton, and A Seidler, and D Sigulem, and O L Ramos
January 1999, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
R Sesso, and M J Klag, and M S Ancao, and P K Whelton, and A Seidler, and D Sigulem, and O L Ramos
April 1986, The New England journal of medicine,
R Sesso, and M J Klag, and M S Ancao, and P K Whelton, and A Seidler, and D Sigulem, and O L Ramos
March 1968, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Copied contents to your clipboard!